Annual D&A
$21.30 M
+$5.70 M+36.54%
31 December 2023
Summary:
Neurocrine Biosciences annual depreciation & amortization is currently $21.30 million, with the most recent change of +$5.70 million (+36.54%) on 31 December 2023. During the last 3 years, it has risen by +$12.70 million (+147.67%). NBIX annual D&A is now at all-time high.NBIX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$6.50 M
-$800.00 K-10.96%
30 September 2024
Summary:
Neurocrine Biosciences quarterly depreciation & amortization is currently $6.50 million, with the most recent change of -$800.00 thousand (-10.96%) on 30 September 2024. Over the past year, it has increased by +$1.00 million (+18.18%). NBIX quarterly D&A is now -10.96% below its all-time high of $7.30 million, reached on 30 June 2024.NBIX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$25.70 M
+$1.00 M+4.05%
30 September 2024
Summary:
Neurocrine Biosciences TTM depreciation & amortization is currently $25.70 million, with the most recent change of +$1.00 million (+4.05%) on 30 September 2024. Over the past year, it has increased by +$5.70 million (+28.50%). NBIX TTM D&A is now at all-time high.NBIX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.5% | +18.2% | +28.5% |
| 3 y3 years | +147.7% | +132.1% | +154.5% |
| 5 y5 years | +432.5% | +225.0% | +286.4% |
NBIX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +147.7% | -11.0% | +132.1% | at high | +154.5% |
| 5 y | 5 years | at high | +432.5% | -11.0% | +225.0% | at high | +286.4% |
| alltime | all time | at high | +3142.0% | -11.0% | +4610.1% | at high | >+9999.0% |
Neurocrine Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $6.50 M(-11.0%) | $25.70 M(+4.0%) |
| June 2024 | - | $7.30 M(+17.7%) | $24.70 M(+9.8%) |
| Mar 2024 | - | $6.20 M(+8.8%) | $22.50 M(+5.6%) |
| Dec 2023 | $21.30 M(+36.5%) | $5.70 M(+3.6%) | $21.30 M(+6.5%) |
| Sept 2023 | - | $5.50 M(+7.8%) | $20.00 M(+8.1%) |
| June 2023 | - | $5.10 M(+2.0%) | $18.50 M(+6.9%) |
| Mar 2023 | - | $5.00 M(+13.6%) | $17.30 M(+10.9%) |
| Dec 2022 | $15.60 M(+43.1%) | $4.40 M(+10.0%) | $15.60 M(+9.9%) |
| Sept 2022 | - | $4.00 M(+2.6%) | $14.20 M(+9.2%) |
| June 2022 | - | $3.90 M(+18.2%) | $13.00 M(+11.1%) |
| Mar 2022 | - | $3.30 M(+10.0%) | $11.70 M(+7.3%) |
| Dec 2021 | $10.90 M(+26.7%) | $3.00 M(+7.1%) | $10.90 M(+7.9%) |
| Sept 2021 | - | $2.80 M(+7.7%) | $10.10 M(+6.3%) |
| June 2021 | - | $2.60 M(+4.0%) | $9.50 M(+5.6%) |
| Mar 2021 | - | $2.50 M(+13.6%) | $9.00 M(+4.7%) |
| Dec 2020 | $8.60 M(+16.2%) | $2.20 M(0.0%) | $8.60 M(+2.4%) |
| Sept 2020 | - | $2.20 M(+4.8%) | $8.40 M(+2.4%) |
| June 2020 | - | $2.10 M(0.0%) | $8.20 M(+3.8%) |
| Mar 2020 | - | $2.10 M(+5.0%) | $7.90 M(+6.8%) |
| Dec 2019 | $7.40 M(+85.0%) | $2.00 M(0.0%) | $7.40 M(+11.3%) |
| Sept 2019 | - | $2.00 M(+11.1%) | $6.65 M(+16.1%) |
| June 2019 | - | $1.80 M(+12.5%) | $5.73 M(+19.0%) |
| Mar 2019 | - | $1.60 M(+27.9%) | $4.81 M(+20.3%) |
| Dec 2018 | $4.00 M(+66.7%) | $1.25 M(+15.8%) | $4.00 M(+15.8%) |
| Sept 2018 | - | $1.08 M(+22.3%) | $3.46 M(+15.5%) |
| June 2018 | - | $883.00 K(+12.3%) | $2.99 M(+10.9%) |
| Mar 2018 | - | $786.00 K(+11.3%) | $2.70 M(+12.4%) |
| Dec 2017 | $2.40 M(+65.2%) | $706.00 K(+14.6%) | $2.40 M(+12.2%) |
| Sept 2017 | - | $616.00 K(+4.6%) | $2.14 M(+10.8%) |
| June 2017 | - | $589.00 K(+20.4%) | $1.93 M(+15.9%) |
| Mar 2017 | - | $489.00 K(+9.9%) | $1.67 M(+14.7%) |
| Dec 2016 | $1.45 M(+44.0%) | $445.00 K(+9.1%) | $1.45 M(+13.7%) |
| Sept 2016 | - | $408.00 K(+25.9%) | $1.28 M(+14.7%) |
| June 2016 | - | $324.00 K(+17.4%) | $1.11 M(+7.0%) |
| Mar 2016 | - | $276.00 K(+2.2%) | $1.04 M(+3.2%) |
| Dec 2015 | $1.01 M(+22.0%) | $270.00 K(+10.7%) | $1.01 M(+4.8%) |
| Sept 2015 | - | $244.00 K(-2.8%) | $963.00 K(+2.9%) |
| June 2015 | - | $251.00 K(+2.9%) | $936.00 K(+4.8%) |
| Mar 2015 | - | $244.00 K(+8.9%) | $893.00 K(+8.0%) |
| Dec 2014 | $827.00 K(+23.2%) | $224.00 K(+3.2%) | $827.00 K(+9.0%) |
| Sept 2014 | - | $217.00 K(+4.3%) | $759.00 K(+6.9%) |
| June 2014 | - | $208.00 K(+16.9%) | $710.00 K(+5.3%) |
| Mar 2014 | - | $178.00 K(+14.1%) | $674.00 K(+0.4%) |
| Dec 2013 | $671.00 K(+2.1%) | $156.00 K(-7.1%) | $671.00 K(-2.9%) |
| Sept 2013 | - | $168.00 K(-2.3%) | $691.00 K(+0.7%) |
| June 2013 | - | $172.00 K(-1.7%) | $686.00 K(+0.9%) |
| Mar 2013 | - | $175.00 K(-0.6%) | $680.00 K(+3.5%) |
| Dec 2012 | $657.00 K(-5.3%) | $176.00 K(+8.0%) | $657.00 K(+5.5%) |
| Sept 2012 | - | $163.00 K(-1.8%) | $623.00 K(+4.2%) |
| June 2012 | - | $166.00 K(+9.2%) | $598.00 K(-1.3%) |
| Mar 2012 | - | $152.00 K(+7.0%) | $606.00 K(-12.7%) |
| Dec 2011 | $694.00 K(-51.7%) | $142.00 K(+2.9%) | $694.00 K(-19.0%) |
| Sept 2011 | - | $138.00 K(-20.7%) | $857.00 K(-19.3%) |
| June 2011 | - | $174.00 K(-27.5%) | $1.06 M(-14.9%) |
| Mar 2011 | - | $240.00 K(-21.3%) | $1.25 M(-13.1%) |
| Dec 2010 | $1.44 M | $305.00 K(-11.1%) | $1.44 M(-15.6%) |
| Sept 2010 | - | $343.00 K(-4.7%) | $1.70 M(-19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | $360.00 K(-15.9%) | $2.12 M(-19.7%) |
| Mar 2010 | - | $428.00 K(-24.9%) | $2.64 M(-17.0%) |
| Dec 2009 | $3.18 M(-58.2%) | $570.00 K(-24.9%) | $3.18 M(-24.0%) |
| Sept 2009 | - | $759.00 K(-13.8%) | $4.18 M(-22.5%) |
| June 2009 | - | $881.00 K(-9.1%) | $5.39 M(-17.2%) |
| Mar 2009 | - | $969.00 K(-38.4%) | $6.51 M(-14.4%) |
| Dec 2008 | $7.61 M(-19.1%) | $1.57 M(-20.2%) | $7.61 M(-7.2%) |
| Sept 2008 | - | $1.97 M(-1.5%) | $8.20 M(-2.9%) |
| June 2008 | - | $2.00 M(-3.2%) | $8.44 M(-5.2%) |
| Mar 2008 | - | $2.07 M(-4.6%) | $8.91 M(-5.3%) |
| Dec 2007 | $9.40 M(-11.0%) | $2.17 M(-2.0%) | $9.40 M(-4.2%) |
| Sept 2007 | - | $2.21 M(-10.3%) | $9.82 M(-4.1%) |
| June 2007 | - | $2.47 M(-3.7%) | $10.24 M(-2.1%) |
| Mar 2007 | - | $2.56 M(-0.7%) | $10.46 M(-1.0%) |
| Dec 2006 | $10.57 M(+4.7%) | $2.58 M(-2.0%) | $10.57 M(-0.2%) |
| Sept 2006 | - | $2.63 M(-2.2%) | $10.59 M(+0.8%) |
| June 2006 | - | $2.69 M(+0.9%) | $10.50 M(+1.8%) |
| Mar 2006 | - | $2.67 M(+2.4%) | $10.32 M(+2.2%) |
| Dec 2005 | $10.09 M(+42.6%) | $2.60 M(+2.3%) | $10.09 M(+3.3%) |
| Sept 2005 | - | $2.54 M(+1.6%) | $9.77 M(+4.9%) |
| June 2005 | - | $2.50 M(+2.6%) | $9.32 M(+12.5%) |
| Mar 2005 | - | $2.44 M(+7.2%) | $8.28 M(+16.9%) |
| Dec 2004 | $7.08 M(+91.8%) | $2.28 M(+8.9%) | $7.08 M(+26.4%) |
| Sept 2004 | - | $2.09 M(+42.5%) | $5.60 M(+23.7%) |
| June 2004 | - | $1.47 M(+18.1%) | $4.53 M(+11.3%) |
| Mar 2004 | - | $1.24 M(+55.6%) | $4.07 M(+10.2%) |
| Dec 2003 | $3.69 M(+19.2%) | $799.00 K(-21.5%) | $3.69 M(-2.9%) |
| Sept 2003 | - | $1.02 M(+0.9%) | $3.80 M(+6.6%) |
| June 2003 | - | $1.01 M(+16.5%) | $3.57 M(+9.3%) |
| Mar 2003 | - | $866.00 K(-4.8%) | $3.26 M(+5.4%) |
| Dec 2002 | $3.10 M(+16.9%) | $910.00 K(+16.2%) | $3.10 M(+6.1%) |
| Sept 2002 | - | $783.00 K(+11.1%) | $2.92 M(+3.4%) |
| June 2002 | - | $705.00 K(+0.7%) | $2.83 M(+2.4%) |
| Mar 2002 | - | $700.00 K(-4.5%) | $2.76 M(+4.0%) |
| Dec 2001 | $2.65 M(+20.6%) | $733.00 K(+6.7%) | $2.65 M(+6.1%) |
| Sept 2001 | - | $687.00 K(+7.7%) | $2.50 M(+5.2%) |
| June 2001 | - | $638.00 K(+7.6%) | $2.37 M(+4.5%) |
| Mar 2001 | - | $593.00 K(+2.2%) | $2.27 M(+3.4%) |
| Dec 2000 | $2.20 M(+4.7%) | $580.00 K(+3.0%) | $2.20 M(-0.9%) |
| Sept 2000 | - | $563.00 K(+5.0%) | $2.22 M(+2.9%) |
| June 2000 | - | $536.00 K(+3.3%) | $2.15 M(+6.7%) |
| Mar 2000 | - | $519.00 K(-13.5%) | $2.02 M(-3.9%) |
| Dec 1999 | $2.10 M(+23.5%) | $600.00 K(+20.0%) | $2.10 M(+10.5%) |
| Sept 1999 | - | $500.00 K(+25.0%) | $1.90 M(0.0%) |
| June 1999 | - | $400.00 K(-33.3%) | $1.90 M(0.0%) |
| Mar 1999 | - | $600.00 K(+50.0%) | $1.90 M(+11.8%) |
| Dec 1998 | $1.70 M(+30.8%) | $400.00 K(-20.0%) | $1.70 M(0.0%) |
| Sept 1998 | - | $500.00 K(+25.0%) | $1.70 M(+13.3%) |
| June 1998 | - | $400.00 K(0.0%) | $1.50 M(0.0%) |
| Mar 1998 | - | $400.00 K(0.0%) | $1.50 M(+15.4%) |
| Dec 1997 | $1.30 M(+30.0%) | $400.00 K(+33.3%) | $1.30 M(+8.3%) |
| Sept 1997 | - | $300.00 K(-25.0%) | $1.20 M(0.0%) |
| June 1997 | - | $400.00 K(+100.0%) | $1.20 M(+20.0%) |
| Mar 1997 | - | $200.00 K(-33.3%) | $1.00 M(0.0%) |
| Dec 1996 | $1.00 M | $300.00 K(0.0%) | $1.00 M(+42.9%) |
| Sept 1996 | - | $300.00 K(+50.0%) | $700.00 K(+75.0%) |
| June 1996 | - | $200.00 K(0.0%) | $400.00 K(+100.0%) |
| Mar 1996 | - | $200.00 K | $200.00 K |
FAQ
- What is Neurocrine Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual D&A year-on-year change?
- What is Neurocrine Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly D&A year-on-year change?
- What is Neurocrine Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM D&A year-on-year change?
What is Neurocrine Biosciences annual depreciation & amortization?
The current annual D&A of NBIX is $21.30 M
What is the all time high annual D&A for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual depreciation & amortization is $21.30 M
What is Neurocrine Biosciences annual D&A year-on-year change?
Over the past year, NBIX annual depreciation & amortization has changed by +$5.70 M (+36.54%)
What is Neurocrine Biosciences quarterly depreciation & amortization?
The current quarterly D&A of NBIX is $6.50 M
What is the all time high quarterly D&A for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly depreciation & amortization is $7.30 M
What is Neurocrine Biosciences quarterly D&A year-on-year change?
Over the past year, NBIX quarterly depreciation & amortization has changed by +$1.00 M (+18.18%)
What is Neurocrine Biosciences TTM depreciation & amortization?
The current TTM D&A of NBIX is $25.70 M
What is the all time high TTM D&A for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM depreciation & amortization is $25.70 M
What is Neurocrine Biosciences TTM D&A year-on-year change?
Over the past year, NBIX TTM depreciation & amortization has changed by +$5.70 M (+28.50%)